|
1 Table of Contents :
1 Table of Contents 2
1.1 List of Tables 16
1.2 List of Figures 22
2 Introduction 25
2.1 What Is This Report About? 25
3 Definitions of the Markets Covered in the Report 26
3.1 Cardiovascular Devices 26
3.2 Cardiac Rhythm Management 26
3.2.1 Pacemakers 26
3.2.1.1 Single Chamber Pacemakers 26
3.2.1.2 Dual Chamber Pacemakers 26
3.2.2 Implantable Cardioverter Defibrillator (ICD) 26
3.2.2.1 Single Chamber Implantable Cardioverter Defibrillator 26
3.2.2.2 Dual Chamber Implantable Cardioverter Defibrillator 26
3.2.3 Cardiovascular Pacing and ICD Leads 27
3.2.4 Cardiac Resynchronization Therapy 27
3.2.4.1 Cardiac Resynchronisation Therapy – Pacemaker 27
3.2.4.2 Cardiac Resynchronisation Therapy – Defibrillator 27
3.3 Cardiovascular monitoring and diagnostic devices 27
3.3.1 ECG Monitoring Equipment 27
3.3.2 ECG Stress Testing Systems 27
3.3.3 Holter Monitoring Systems 27
3.3.4 Event Monitoring Systems 27
3.4 Cardiovascular prosthetic device 28
3.4.1 Prosthetic heart valves 28
3.4.1.1 Mechanical heart valves 28
3.4.1.2 Tissue heart valve 28
3.4.2 Cardiac Valve Repair 28
3.4.3 Cardiac assist devices (Ventricular Assist Device (VAD)) 28
3.4.3.1 Total Artificial Heart (TAH) 28
3.4.3.2 Intra Aortic Balloon Pump (IABP) 28
3.4.3.3 Intra Aortic Balloon Pump Catheters 28
3.5 Cardiovascular Surgery 29
3.5.1 Beating Heart Systems 29
3.5.2 Perfusion Systems 29
3.5.3 Cardiac Ablation Devices 29
3.5.4 Cardiopulmonary Bypass Equipment 29
3.5.5 Perfusion Disposables 29
3.5.5.1 Oxygenators 29
3.5.5.2 Custom Packs 29
3.6 Electrophysiology 30
3.6.1 Electrophysiology diagnostic catheter 30
3.6.2 Electrophysiology ablation catheter 30
3.6.3 Electrophysiology lab systems 30
3.7 Interventional cardiology 30
3.7.1 Coronary Stents 30
3.7.1.1 Bare Metal Stents 30
3.7.1.2 Drug Eluting Coronary Stents 30
3.7.2 Cardiac Catheters 30
3.7.2.1 Guiding Catheters 31
3.7.2.2 Angiography catheters 31
3.7.3 Percutaneous Transluminal Coronary Balloon (PTCA) Balloon Catheters 31
3.7.3.1 Rapid Exchange PTCA Balloon Catheters 31
3.7.3.2 Over the Wire PTCA Balloon Catheters 31
3.7.3.3 Fixed Wire (FW) PTCA Balloon Catheters 31
3.7.4 Coronary Guidewire 31
3.7.5 Arteriotomy Closure Devices 31
3.8 Peripheral vascular devices 32
3.8.1 Peripheral Vascular Stents 32
3.8.2 Inferior Vena Cava Filter 32
3.8.3 PTA Balloon 32
3.8.4 Aortic Stent Graft 32
3.8.5 Embolic Protection Device 32
3.8.6 Synthetic Surgical Grafts 32
3.8.7 Peripheral Guidewire 32
4 Healthcare Sector Review 33
4.1 Healthcare Sector 33
4.2 Healthcare Expenditure 33
4.3 Healthcare Infrastructure 37
4.3.1 Healthcare Personnel Data 37
4.3.2 Healthcare Facilities Data 39
4.4 Healthcare Policy 44
5 Regulation System 45
5.1 Regulation System 45
5.2 Medical Equipment Approval Process 45
5.2.1 Classification of Medical Devices 45
5.3 Conformity Assessment Process 54
5.3.1 Class I devices 54
5.3.2 Class IIa devices 55
5.3.3 Class IIb devices 56
5.3.4 Class III devices 57
5.4 Post Market Surveillance 58
6 Pricing and Reimbursement 59
6.1 SHI 59
6.1.1 Private Health Insurance 59
6.1.2 Diagnosis Related Groups (DRG) 59
7 Distribution Structure 60
8 Cardiovascular Devices In Germany 61
8.1 Cardiovascular Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015 61
8.2 Cardiovascular Devices, Germany, Overall Revenue ($ mn), 2000-2015 62
8.3 Cardiovascular Devices, Germany, Category Volume (Units), 2000-2015 68
8.4 Cardiovascular Devices, Germany, Company Share (2007-2008) 73
9 Cardiac Rhythm Management In Germany 74
9.1 Cardiac Rhythm Management Overall Revenue (2000-2015) 74
9.1.1 Cardiac Resynchronisation Therapy Overall Revenue (2000-2015) 76
9.1.2 Implantable Cardioverter Defibrillator Overall Revenue (2000-2015) 78
9.2 Cardiac Rhythm Management Overall Volume (2000-2015) 82
9.2.1 Cardiac Resynchronisation Therapy Overall Volume (2000-2015) 84
9.2.2 Implantable Cardioverter Defibrillator Overall Volume (2000-2015) 86
9.2.3 Pacemaker Overall Volume (2000-2015) 88
9.3 Cardiac Rhythm Management Average Price (2000-2015) 90
9.4 Cardiac Rhythm Management Distribution Share (2007-2008) 91
9.5 Cardiac Rhythm Management, Germany, Company Share (2007-2008) 92
10 Cardiovascular Monitoring and Diagnostic Devices In Germany 93
10.1 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2000-2015) 93
10.2 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2000-2015) 96
10.3 Cardiovascular Monitoring and Diagnostic Devices Average Price (2000-2015) 98
10.4 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2007-2008) 99
10.5 Cardiovascular Monitoring and Diagnostic Devices, Germany, Company Share (2007-2008) 100
11 Cardiovascular Prosthetic Devices In Germany 102
11.1 Cardiovascular Prosthetic Devices Overall Revenue (2000-2015) 102
11.1.1 Cardiac Assist Devices Overall Revenue (2000-2015) 104
11.1.2 Prosthetic Heart Valve Overall Revenue (2000-2015) 106
11.2 Cardiovascular Prosthetic Devices Overall Volume (2000-2015) 108
11.2.1 Cardiac Assist Devices Overall Volume (2000-2015) 110
11.2.2 Prosthetic Heart Valve Overall Volume (2000-2015) 112
11.3 Cardiovascular Prosthetic Devices Average Price (2000-2015) 114
11.4 Cardiovascular Prosthetic Devices Distribution Share (2007-2008) 115
11.5 Cardiovascular Prosthetic Devices, Germany, Company Share (2007-2008) 116
12 Cardiovascular Surgery In Germany 117
12.1 Cardiovascular Surgery Overall Revenue (2000-2015) 117
12.1.1 Perfusion Disposables Overall Revenue (2000-2015) 119
12.2 Cardiovascular Surgery Overall Volume (2000-2015) 121
12.2.1 Perfusion Disposables Overall Volume (2000-2015) 122
12.3 Cardiovascular Surgery Average Price (2000-2015) 124
12.4 Cardiovascular Surgery Distribution Share (2007-2008) 125
12.5 Cardiovascular Surgery, Germany, Company Share (2007-2008) 126
13 Electrophysiology In Germany 127
13.1 Electrophysiology Overall Revenue (2000-2015) 127
13.2 Electrophysiology Overall Volume (2000-2015) 129
13.3 Electrophysiology Average Price (2000-2015) 130
13.4 Electrophysiology Distribution Share (2007-2008) 131
13.5 Electrophysiology, Germany, Company Share (2007-2008) 132
14 Interventional Cardiology In Germany 134
14.1 Interventional Cardiology Overall Revenue (2000-2015) 134
14.1.1 Cardiac Catheter Overall Revenue (2000-2015) 138
14.1.2 Coronary Stent Overall Revenue (2000-2015) 140
14.1.3 PTCA Balloon Overall Revenue (2000-2015) 142
14.2 Interventional Cardiology Overall Volume (2000-2015) 144
14.2.1 Cardiac Catheter Overall Volume (2000-2015) 146
14.2.2 Coronary Stent Overall Volume (2000-2015) 148
14.2.3 PTCA Balloon Overall Volume (2000-2015) 150
14.3 Interventional Cardiology Average Price (2000-2015) 152
14.4 Interventional Cardiology Distribution Share (2007-2008) 154
14.5 Interventional Cardiology, Germany, Company Share (2007-2008) 155
15 Peripheral Vascular Devices In Germany 156
15.1 Peripheral Vascular Devices Overall Revenue (2000-2015) 156
15.2 Peripheral Vascular Devices Overall Volume (2000-2015) 160
15.3 Peripheral Vascular Devices Average Price (2000-2015) 162
15.4 Peripheral Vascular Devices Distribution Share (2007-2008) 163
15.5 Peripheral Vascular Devices, Germany, Company Share (2007-2008) 164
16 Overview of Key Companies in Germany Cardiovascular Devices Market 165
16.1 Boston Scientific Corporation 165
16.1.1 Company Overview 165
16.1.2 Value Chain Analysis 166
16.1.2.1 Manufacturing 166
16.1.2.2 Product Development 167
16.1.2.3 Sales and Marketing 168
16.1.3 Boston Scientific Corporation Pipeline Products 169
16.1.3.1 Boston Scientific Corporation Pipeline Products by Equipment Type 169
16.1.3.2 Boston Scientific Corporation Pipeline Products by Development Stage 170
16.1.3.3 Boston Scientific Corporation Pipeline Products by Therapy Area 171
16.1.3.4 Boston Scientific Corporation Pipeline Products by Clinical Trials 172
16.1.3.5 Boston Scientific Corporation Pipeline Products by News Summary 173
16.2 Medtronic, Inc. 175
16.2.1 Company Overview 175
16.2.2 Value Chain Analysis 175
16.2.2.1 Manufacturing 176
16.2.2.2 Product Development 176
16.2.2.3 Sales and Marketing 176
16.2.3 Medtronic, Inc. Pipeline Products 177
16.2.3.1 Medtronic, Inc. Pipeline Products by Equipment Type 177
16.2.3.2 Medtronic, Inc. Pipeline Products by Development Stage 179
16.2.3.3 Medtronic, Inc. Pipeline Products by Therapy Area 181
16.2.3.4 Medtronic, Inc. Pipeline Products by Clinical Trials 183
16.2.3.5 Medtronic, Inc. Pipeline Products by News Summary 184
16.3 Cordis Corporation 185
16.3.1 Company Overview 185
16.3.2 Cordis Corporation Pipeline Products 185
16.3.2.1 Cordis Corporation Pipeline Products by Equipment Type 185
16.3.2.2 Cordis Corporation Pipeline Products by Development Stage 186
16.3.2.3 Cordis Corporation Pipeline Products by Therapy Area 186
16.3.2.4 Cordis Corporation Pipeline Products by Clinical Trials 187
16.3.2.5 Cordis Corporation Pipeline Products by News Summary 187
16.4 Abbott Laboratories 188
16.4.1 Company Overview 188
16.4.2 Value Chain Analysis 189
16.4.2.1 Manufacturing 189
16.4.2.2 Product Development 189
16.4.2.3 Sales and Marketing 191
16.5 St. Jude Medical Inc. 192
16.5.1 Company Overview 192
16.5.2 Value Chain Analysis 192
16.5.2.1 Manufacturing 193
16.5.2.2 Product Development 193
16.5.2.3 Sales and Marketing 194
16.5.3 St. Jude Medical Inc. Pipeline Products 195
16.5.3.1 St. Jude Medical Inc. Pipeline Products by Equipment Type 195
16.5.3.2 St. Jude Medical Inc. Pipeline Products by Development Stage 195
16.5.3.3 St. Jude Medical Inc. Pipeline Products by Therapy Area 196
16.5.3.4 St. Jude Medical Inc. Pipeline Products by Clinical Trials 196
16.5.3.5 St. Jude Medical Inc. Pipeline Products by News Summary 197
16.6 BIOTRONIK GmbH & Co. KG 198
16.6.1 Company Overview 198
16.6.2 BIOTRONIK GmbH & Co. KG Pipeline Products 198
16.6.2.1 BIOTRONIK GmbH & Co. KG Pipeline Products by Equipment Type 198
16.6.2.2 BIOTRONIK GmbH & Co. KG Pipeline Products by Development Stage 198
16.6.2.3 BIOTRONIK GmbH & Co. KG Pipeline Products by Therapy Area 199
16.6.2.4 BIOTRONIK GmbH & Co. KG Pipeline Products by Clinical Trials 199
16.6.2.5 BIOTRONIK GmbH & Co. KG Pipeline Products by News Summary 199
16.7 Sorin S.p.A. 200
16.7.1 Company Overview 200
16.7.2 Value Chain Analysis 201
16.7.2.1 Manufacturing 201
16.7.2.2 Product Development 201
16.7.2.3 Sales and Marketing 203
16.7.3 Sorin Group Pipeline Products 204
16.7.3.1 Sorin Group Pipeline Products by Equipment Type 204
16.7.3.2 Sorin Group Pipeline Products by Development Stage 205
16.7.3.3 Sorin Group Pipeline Products by Therapy Area 205
16.7.3.4 Sorin Group Pipeline Products by Clinical Trials 206
16.7.3.5 Sorin Group Pipeline Products by News Summary 206
16.8 GE Healthcare 207
16.8.1 Company Overview 207
16.9 Philips Healthcare 208
16.9.1 Company Overview 208
16.9.2 Value Chain Analysis 208
16.9.2.1 Manufacturing 209
16.9.2.2 Product Development 209
16.9.2.3 Sales and Marketing 210
16.9.3 Philips Medical Systems Pipeline Products 211
16.9.3.1 Philips Medical Systems Pipeline Products by Equipment Type 211
16.9.3.2 Philips Medical Systems Pipeline Products by Development Stage 211
16.9.3.3 Philips Medical Systems Pipeline Products by Therapy Area 212
16.9.3.4 Philips Medical Systems Pipeline Products by Clinical Trials 212
16.9.3.5 Philips Medical Systems Pipeline Products by News Summary 212
16.10 OSI Systems, Inc. 213
16.10.1 Company Overview 213
16.10.2 Value Chain Analysis 214
16.10.2.1 Manufacturing 214
16.10.2.2 Product Development 215
16.10.2.3 Sales and Marketing 215
16.11 Cardiac Science Corporation 216
16.11.1 Company Overview 216
16.11.2 Value Chain Analysis 217
16.11.2.1 Manufacturing 217
16.11.2.2 Product Development 218
16.11.2.3 Sales and Marketing 218
16.12 Nihon Kohden Corporation 219
16.12.1 Company Overview 219
16.12.2 Value Chain Analysis 220
16.12.2.1 Manufacturing 220
16.12.2.2 Product Development 220
16.12.2.3 Sales and Marketing 221
16.13 Welch Allyn Inc. 222
16.13.1 Company Overview 222
16.14 Card Guard AG 222
16.14.1 Company Overview 222
16.15 Edwards Lifesciences Corporation 223
16.15.1 Company Overview 223
16.15.2 Value Chain Analysis 223
16.15.2.1 Manufacturing 224
16.15.2.2 Product Development 224
16.15.2.3 Sales and Marketing 225
16.15.3 Edwards Lifesciences Corporation Pipeline Products 225
16.15.3.1 Edwards Lifesciences Corporation Pipeline Products by Equipment Type 225
16.15.3.2 Edwards Lifesciences Corporation Pipeline Products by Development Stage 226
16.15.3.3 Edwards Lifesciences Corporation Pipeline Products by Therapy Area 226
16.15.3.4 Edwards Lifesciences Corporation Pipeline Products by Clinical Trials 227
16.15.3.5 Edwards Lifesciences Corporation Pipeline Products by News Summary 227
16.16 Thoratec Corporation 228
16.16.1 Company Overview 228
16.16.2 Value Chain Analysis 229
16.16.2.1 Manufacturing 229
16.16.2.2 Product Development 230
16.16.2.3 Sales and Marketing 230
16.16.3 Thoratec Corporation Pipeline Products 231
16.16.3.1 Thoratec Corporation Pipeline Products by Equipment Type 231
16.16.3.2 Thoratec Corporation Pipeline Products by Development Stage 231
16.16.3.3 Thoratec Corporation Pipeline Products by Therapy Area 231
16.16.3.4 Thoratec Corporation Pipeline Products by Clinical Trials 232
16.16.3.5 Thoratec Corporation Pipeline Products by News Summary 232
16.17 Datascope Corporation 233
16.17.1 Company Overview 233
16.17.2 Value Chain Analysis 233
16.17.2.1 Manufacturing 234
16.17.2.2 Product Development 234
16.17.2.3 Sales and Marketing 235
16.18 Arrow International, Inc. 236
16.18.1 Company Overview 236
16.18.2 Value Chain Analysis 237
16.18.2.1 Manufacturing 237
16.18.2.2 Product Development 237
16.18.2.3 Sales and Marketing 238
16.18.3 Arrow International, Inc. Pipeline Products 239
16.18.3.1 Arrow International, Inc. Pipeline Products by Equipment Type 239
16.18.3.2 Arrow International, Inc. Pipeline Products by Development Stage 239
16.18.3.3 Arrow International, Inc. Pipeline Products by Therapy Area 239
16.18.3.4 Arrow International, Inc. Pipeline Products by Clinical Trials 239
16.19 ABIOMED, Inc. 240
16.19.1 Company Overview 240
16.19.2 Value Chain Analysis 241
16.19.2.1 Manufacturing 241
16.19.2.2 Product Development 242
16.19.2.3 Sales and Marketing 242
16.19.3 ABIOMED, Inc. Pipeline Products 243
16.19.3.1 ABIOMED, Inc. Pipeline Products by Equipment Type 243
16.19.3.2 ABIOMED, Inc. Pipeline Products by Development Stage 243
16.19.3.3 ABIOMED, Inc. Pipeline Products by Therapy Area 243
16.19.3.4 ABIOMED, Inc. Pipeline Products by Clinical Trials 244
16.19.3.5 ABIOMED, Inc. Pipeline Products by News Summary 244
16.20 MAQUET GmbH & Co. KG 245
16.20.1 Company Overview 245
16.21 AtriCure, Inc. 246
16.21.1 Company Overview 246
16.21.2 AtriCure, Inc. Pipeline Products 246
16.21.2.1 AtriCure, Inc. Pipeline Products by Equipment Type 246
16.21.2.2 AtriCure, Inc. Pipeline Products by Development Stage 246
16.21.2.3 AtriCure, Inc. Pipeline Products by Therapy Area 247
16.21.2.4 AtriCure, Inc. Pipeline Products by Clinical Trials 247
16.21.2.5 AtriCure, Inc. Pipeline Products by News Summary 247
16.22 Terumo Corporation 248
16.22.1 Company Overview 248
16.22.2 Value Chain Analysis 248
16.22.2.1 Manufacturing 249
16.22.2.2 Product Development 249
16.22.2.3 Sales and Marketing 249
16.22.3 Terumo Corporation Pipeline Products 250
16.22.3.1 Terumo Corporation Pipeline Products by Equipment Type 250
16.22.3.2 Terumo Corporation Pipeline Products by Development Stage 250
16.22.3.3 Terumo Corporation Pipeline Products by Therapy Area 250
16.22.3.4 Terumo Corporation Pipeline Products by Clinical Trials 251
16.22.3.5 Terumo Corporation Pipeline Products by News Summary 251
16.23 Biosense Webster, Inc. 252
16.23.1 Company Overview 252
16.24 CryoCath Technologies Inc. 253
16.24.1 Company Overview 253
16.24.2 CryoCath Technologies Inc. Pipeline Products 253
16.24.2.1 CryoCath Technologies Inc. Pipeline Products by Equipment Type 253
16.24.2.2 CryoCath Technologies Inc. Pipeline Products by Development Stage 253
16.24.2.3 CryoCath Technologies Inc. Pipeline Products by Therapy Area 253
16.24.2.4 CryoCath Technologies Inc. Pipeline Products by Clinical Trials 254
16.24.2.5 CryoCath Technologies Inc. Pipeline Products by News Summary 254
16.25 Siemens Healthcare 255
16.25.1 Company Overview 255
16.25.2 Value Chain Analysis 256
16.25.2.1 Manufacturing 256
16.25.2.2 Product Development 257
16.25.2.3 Sales and Marketing 257
16.26 C.R. Bard, Inc. 258
16.26.1 Company Overview 258
16.26.2 Value Chain Analysis 258
16.26.2.1 Manufacturing 259
16.26.2.2 Product Development 259
16.26.2.3 Sales and Marketing 259
16.26.3 C.R. Bard, Inc. Pipeline Products 260
16.26.3.1 C.R. Bard, Inc. Pipeline Products by Equipment Type 260
16.26.3.2 C.R. Bard, Inc. Pipeline Products by Development Stage 261
16.26.3.3 C.R. Bard, Inc. Pipeline Products by Therapy Area 261
16.26.3.4 C.R. Bard, Inc. Pipeline Products by Clinical Trials 262
16.27 Invatec S.r.l. 263
16.27.1 Company Overview 263
16.27.2 Invatec S.r.l. Pipeline Products 263
16.27.2.1 Invatec S.r.l. Pipeline Products by Equipment Type 263
16.27.2.2 Invatec S.r.l. Pipeline Products by Development Stage 264
16.27.2.3 Invatec S.r.l. Pipeline Products by Therapy Area 265
16.27.2.4 Invatec S.r.l. Pipeline Products by Clinical Trials 266
16.27.2.5 Invatec S.r.l. Pipeline Products by News Summary 266
16.28 ev3 Inc. 267
16.28.1 Company Overview 267
16.28.2 Value Chain Analysis 268
16.28.2.1 Manufacturing 268
16.28.2.2 Product Development 269
16.28.2.3 Sales and Marketing 269
16.28.3 ev3 Inc. Pipeline Products 270
16.28.3.1 ev3 Inc. Pipeline Products by Equipment Type 270
16.28.3.2 ev3 Inc. Pipeline Products by Development Stage 270
16.28.3.3 ev3 Inc. Pipeline Products by Therapy Area 271
16.28.3.4 ev3 Inc. Pipeline Products by Clinical Trials 271
16.28.3.5 ev3 Inc. Pipeline Products by News Summary 271
16.29 Aachen Resonance GmbH 272
16.29.1 Company Overview 272
16.30 allgaier instrumente GmbH 272
16.30.1 Company Overview 272
16.31 Bavaria Medizin Technologie GmbH 272
16.31.1 Company Overview 272
16.32 Dispomedica GmbH 273
16.32.1 Company Overview 273
16.33 BMDSys GmbH 273
16.33.1 Company Overview 273
16.34 adeor Medical Technologies GmbH 273
16.34.1 Company Overview 273
16.35 Endosmart GmbH 274
16.35.1 Company Overview 274
16.36 Admedes Schuessler GmbH 274
16.36.1 Company Overview 274
16.37 Weinmann Gerate far Medizin GmbH & Co.KG 275
16.37.1 Company Overview 275
16.38 CINVENTION AG 275
16.38.1 Company Overview 275
16.39 Berlin Heart GmbH 276
16.39.1 Company Overview 276
16.39.2 Berlin Heart GmbH Pipeline Products 276
16.39.2.1 Berlin Heart GmbH Pipeline Products by Equipment Type 276
16.39.2.2 Berlin Heart GmbH Pipeline Products by Development Stage 276
16.39.2.3 Berlin Heart GmbH Pipeline Products by Therapy Area 277
16.39.2.4 Berlin Heart GmbH Pipeline Products by Clinical Trials 277
16.39.2.5 Berlin Heart GmbH Pipeline Products by News Summary 277
16.40 BMDSys GmbH 278
16.40.1 Company Overview 278
16.41 CardioBridge GmbH 279
16.41.1 Company Overview 279
16.41.2 CardioBridge GmbH Pipeline Products 279
16.41.2.1 CardioBridge GmbH Pipeline Products by Equipment Type 279
16.41.2.2 CardioBridge GmbH Pipeline Products by Development Stage 279
16.41.2.3 CardioBridge GmbH Pipeline Products by Therapy Area 279
16.41.2.4 CardioBridge GmbH Pipeline Products by Clinical Trials 280
16.41.2.5 CardioBridge GmbH Pipeline Products by News Summary 280
16.42 Endosmart GmbH 280
16.42.1 Company Overview 280
16.43 Eurocor GmbH 281
16.43.1 Company Overview 281
16.43.2 Eurocor GmbH Pipeline Products 281
16.43.2.1 Eurocor GmbH Pipeline Products by Equipment Type 281
16.43.2.2 Eurocor GmbH Pipeline Products by Development Stage 282
16.43.2.3 Eurocor GmbH Pipeline Products by Therapy Area 282
16.43.2.4 Eurocor GmbH Pipeline Products by Clinical Trials 283
16.43.2.5 Eurocor GmbH Pipeline Products by News Summary 283
16.44 JenaValve Technology GmbH 284
16.44.1 Company Overview 284
16.44.2 JenaValve Technology GmbH Pipeline Products 284
16.44.2.1 JenaValve Technology GmbH Pipeline Products by Equipment Type 284
16.44.2.2 JenaValve Technology GmbH Pipeline Products by Development Stage 284
16.44.2.3 JenaValve Technology GmbH Pipeline Products by Therapy Area 284
16.45 Translumina GmbH 285
16.45.1 Company Overview 285
16.45.2 Translumina GmbH Pipeline Products 285
16.45.2.1 Translumina GmbH Pipeline Products by Equipment Type 285
16.45.2.2 Translumina GmbH Pipeline Products by Development Stage 285
16.45.2.3 Translumina GmbH Pipeline Products by Therapy Area 286
16.45.2.4 Translumina GmbH Pipeline Products by Clinical Trials 286
17 Recent Developments 287
17.1 Legal and Regulatory 287
17.1.1 Mar 19, 2009: Edwards Lifesciences Prevails In German Patent Infringement Case Initiated By Cook 287
17.1.2 Jan 29, 2009: AGA Begins Proceedings Against Occlutech To Recover Damages 287
17.1.3 Jan 06, 2009: German Appeals Court Rules In Favor Of AGA Medical In Lawsuit Against Occlutech 287
17.2 Product News 288
17.2.1 Mar 30, 2009: BIOTRONIK Announces World Wide Launch Of BIOTRONIK Home Monitoring 288
18 Appendix 290
18.1 Global Markets Direct Research Methodology 290
18.2 Coverage 291
18.3 Secondary Research 291
18.4 Primary Research 292
18.5 Models 292
18.6 Forecasts 293
18.7 Expert Panel Validation 293
18.8 Currency Conversion 294
18.9 Contact Us 295
18.10 Disclaimer 295
1.1 List of Tables
Table 1: Healthcare Personnel by Region in Germany, 2004 37
Table 2: Doctors by Specialty in Germany, 2000-2004 38
Table 3: Hospitals by Region in Germany, 2004 39
Table 4: Hospital Beds by Region in Germany, 2004 40
Table 5: Rehabilitation Centers by Region in Germany, 2004 41
Table 6: Rehabilitation Center Beds by Region in Germany, 2004 42
Table 7: Discharges by Diagnosis in Germany, 2004 43
Table 8: Cardiovascular Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015 61
Table 9: Cardiovascular Devices, Germany, Overall Revenue ($ mn), 2000-2015 62
Table 10: Cardiovascular Devices, Germany, Cross-Category Analysis, 2000-2015 63
Table 11: Cardiovascular Devices, Germany, Overall Revenue ($ mn), Historic, 2000-2008 65
Table 12: Cardiovascular Devices, Germany, Overall Revenue ($ mn), Forecast, 2008-2015 67
Table 13: Cardiovascular Devices, Germany, Category Volume (Units), 2000-2015 68
Table 14: Cardiovascular Devices, Germany, Category Volume (Units), Historic, 2000-2008 70
Table 15: Cardiovascular Devices, Germany, Category Volume (Units), Forecast, 2008-2015 72
Table 16: Cardiovascular Devices, Germany, Company Share by Revenue ($ mn), 2007-2008 73
Table 17: Cardiac Rhythm Management, Germany, Revenue ($ mn) by Segment, Historic, 2000-2008 74
Table 18: Cardiac Rhythm Management, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015 75
Table 19: Cardiac Resynchronisation Therapy, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 76
Table 20: Cardiac Resynchronisation Therapy, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 77
Table 21: Implantable Cardioverter Defibrillator, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 78
Table 22: Implantable Cardioverter Defibrillator, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 79
Table 23: Pacemaker, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 80
Table 24: Pacemaker, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 81
Table 25: Cardiac Rhythm Management, Germany, Volume (Units) by Segment, Historic, 2000-2008 82
Table 26: Cardiac Rhythm Management, Germany, Volume (Units) by Segment, Forecast, 2008-2015 83
Table 27: Cardiac Resynchronisation Therapy, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008 84
Table 28: Cardiac Resynchronisation Therapy, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015 85
Table 29: Implantable Cardioverter Defibrillator, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008 86
Table 30: Implantable Cardioverter Defibrillator, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015 87
Table 31: Pacemaker, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008 88
Table 32: Pacemaker, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015 89
Table 33: Cardiac Rhythm Management, Germany, Average Price ($), Historic, 2000-2008 90
Table 34: Cardiac Rhythm Management, Germany, Average Price ($), Forecast, 2008-2015 90
Table 35: Cardiac Rhythm Management, Germany, Distribution Share by Revenue ($mn), 2007-2008 91
Table 36: Cardiac Rhythm Management, Germany, Company Share by Revenue ($ mn), 2007-2008 92
Table 37: Cardiovascular Monitoring and Diagnostic Devices, Germany, Revenue ($ mn) by Segment, Historic, 2000-2008 94
Table 38: Cardiovascular Monitoring and Diagnostic Devices, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015 95
Table 39: Cardiovascular Monitoring and Diagnostic Devices, Germany, Volume (Units) by Segment, Historic, 2000-2008 96
Table 40: Cardiovascular Monitoring and Diagnostic Devices, Germany, Volume (Units) by Segment, Forecast, 2008-2015 97
Table 41: Cardiovascular Monitoring and Diagnostic Devices, Germany, Average Price ($), Historic, 2000-2008 98
Table 42: Cardiovascular Monitoring and Diagnostic Devices, Germany, Average Price ($), Forecast, 2008-2015 98
Table 43: Cardiovascular Monitoring and Diagnostic Devices, Germany, Distribution Share by Revenue ($mn), 2007-2008 99
Table 44: Cardiovascular Monitoring and Diagnostic Devices, Germany, Company Share by Revenue ($ mn), 2007-2008 101
Table 45: Cardiovascular Prosthetic Devices, Germany, Revenue ($ mn) by Segment, Historic, 2000-2008 102
Table 46: Cardiovascular Prosthetic Devices, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015 103
Table 47: Cardiac Assist Devices, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 104
Table 48: Cardiac Assist Devices, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 105
Table 49: Prosthetic Heart Valve, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 106
Table 50: Prosthetic Heart Valve, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 107
Table 51: Cardiovascular Prosthetic Devices, Germany, Volume (Units) by Segment, Historic, 2000-2008 108
Table 52: Cardiovascular Prosthetic Devices, Germany, Volume (Units) by Segment, Forecast, 2008-2015 109
Table 53: Cardiac Assist Devices, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008 110
Table 54: Cardiac Assist Devices, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015 111
Table 55: Prosthetic Heart Valve, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008 112
Table 56: Prosthetic Heart Valve, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015 113
Table 57: Cardiovascular Prosthetic Devices, Germany, Average Price ($), Historic, 2000-2008 114
Table 58: Cardiovascular Prosthetic Devices, Germany, Average Price ($), Forecast, 2008-2015 114
Table 59: Cardiovascular Prosthetic Devices, Germany, Distribution Share by Revenue ($mn), 2007-2008 115
Table 60: Cardiovascular Prosthetic Devices, Germany, Company Share by Revenue ($ mn), 2007-2008 116
Table 61: Cardiovascular Surgery, Germany, Revenue ($ mn) by Segment, Historic, 2000-2008 117
Table 62: Cardiovascular Surgery, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015 118
Table 63: Perfusion Disposables, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 119
Table 64: Perfusion Disposables, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 120
Table 65: Cardiovascular Surgery, Germany, Volume (Units) by Segment, Historic, 2000-2008 121
Table 66: Cardiovascular Surgery, Germany, Volume (Units) by Segment, Forecast, 2008-2015 121
Table 67: Perfusion Disposables, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008 122
Table 68: Perfusion Disposables, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015 123
Table 69: Cardiovascular Surgery, Germany, Average Price ($), Historic, 2000-2008 124
Table 70: Cardiovascular Surgery, Germany, Average Price ($), Forecast, 2008-2015 124
Table 71: Cardiovascular Surgery, Germany, Distribution Share by Revenue ($mn), 2007-2008 125
Table 72: Cardiovascular Surgery, Germany, Company Share by Revenue ($ mn), 2007-2008 126
Table 73: Electrophysiology, Germany, Revenue ($ mn) by Segment, Historic, 2000-2008 127
Table 74: Electrophysiology, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015 128
Table 75: Electrophysiology, Germany, Volume (Units) by Segment, Historic, 2000-2008 129
Table 76: Electrophysiology, Germany, Volume (Units) by Segment, Forecast, 2008-2015 129
Table 77: Electrophysiology, Germany, Average Price ($), Historic, 2000-2008 130
Table 78: Electrophysiology, Germany, Average Price ($), Forecast, 2008-2015 130
Table 79: Electrophysiology, Germany, Distribution Share by Revenue ($mn), 2007-2008 131
Table 80: Electrophysiology, Germany, Company Share by Revenue ($ mn), 2007-2008 133
Table 81: Interventional Cardiology, Germany, Revenue ($ mn) by Segment, Historic, 2000-2008 135
Table 82: Interventional Cardiology, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015 137
Table 83: Cardiac Catheter, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 138
Table 84: Cardiac Catheter, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 139
Table 85: Coronary Stent, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 140
Table 86: Coronary Stent, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 141
Table 87: PTCA Balloon, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 142
Table 88: PTCA Balloon, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 143
Table 89: Interventional Cardiology, Germany, Volume (Units) by Segment, Historic, 2000-2008 144
Table 90: Interventional Cardiology, Germany, Volume (Units) by Segment, Forecast, 2008-2015 145
Table 91: Cardiac Catheter, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008 146
Table 92: Cardiac Catheter, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015 147
Table 93: Coronary Stent, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008 148
Table 94: Coronary Stent, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015 149
Table 95: PTCA Balloon, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008 150
Table 96: PTCA Balloon, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015 151
Table 97: Interventional Cardiology, Germany, Average Price ($), Historic, 2000-2008 152
Table 98: Interventional Cardiology, Germany, Average Price ($), Forecast, 2008-2015 153
Table 99: Interventional Cardiology, Germany, Distribution Share by Revenue ($mn), 2007-2008 154
Table 100: Interventional Cardiology, Germany, Company Share by Revenue ($ mn), 2007-2008 155
Table 101: Peripheral Vascular Devices, Germany, Revenue ($ mn) by Segment, Historic, 2000-2008 157
Table 102: Peripheral Vascular Devices, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015 159
Table 103: Peripheral Vascular Devices, Germany, Volume (Units) by Segment, Historic, 2000-2008 160
Table 104: Peripheral Vascular Devices, Germany, Volume (Units) by Segment, Forecast, 2008-2015 161
Table 105: Peripheral Vascular Devices, Germany, Average Price ($), Historic, 2000-2008 162
Table 106: Peripheral Vascular Devices, Germany, Average Price ($), Forecast, 2008-2015 162
Table 107: Peripheral Vascular Devices, Germany, Distribution Share by Revenue ($mn), 2007-2008 163
Table 108: Peripheral Vascular Devices, Germany, Company Share by Revenue ($ mn), 2007-2008 164
Table 109: Boston Scientific Corporation Pipeline Products by Equipment Type 169
Table 110: Boston Scientific Corporation Pipeline Products by Development Stage 170
Table 111: Boston Scientific Corporation Pipeline Products by Therapy Area 171
Table 112: Boston Scientific Corporation Pipeline Products by Clinical Trials 172
Table 113: Boston Scientific Corporation Pipeline Products by News Summaries 173
Table 114: Medtronic, Inc. Pipeline Products by Equipment Type 177
Table 115: Medtronic, Inc. Pipeline Products by Development Stage 179
Table 116: Medtronic, Inc. Pipeline Products by Therapy Area 181
Table 117: Medtronic, Inc. Pipeline Products by Clinical Trials 183
Table 118: Medtronic, Inc. Pipeline Products by News Summaries 184
Table 119: Cordis Corporation Pipeline Products by Equipment Type 185
Table 120: Cordis Corporation Pipeline Products by Development Stage 186
Table 121: Cordis Corporation Pipeline Products by Therapy Area 186
Table 122: Cordis Corporation Pipeline Products by Clinical Trials 187
Table 123: Cordis Corporation Pipeline Products by News Summaries 187
Table 124: St. Jude Medical Inc. Pipeline Products by Equipment Type 195
Table 125: St. Jude Medical Inc. Pipeline Products by Development Stage 195
Table 126: St. Jude Medical Inc. Pipeline Products by Therapy Area 196
Table 127: St. Jude Medical Inc. Pipeline Products by Clinical Trials 196
Table 128: St. Jude Medical Inc. Pipeline Products by News Summaries 197
Table 129: BIOTRONIK GmbH & Co. KG Pipeline Products by Equipment Type 198
Table 130: BIOTRONIK GmbH & Co. KG Pipeline Products by Development Stage 198
Table 131: BIOTRONIK GmbH & Co. KG Pipeline Products by Therapy Area 199
Table 132: BIOTRONIK GmbH & Co. KG Pipeline Products by Clinical Trials 199
Table 133: BIOTRONIK GmbH & Co. KG Pipeline Products by News Summary 199
Table 134: Sorin Group Pipeline Products by Equipment Type 204
Table 135: Sorin Group Pipeline Products by Development Stage 205
Table 136: Sorin Group Pipeline Products by Therapy Area 205
Table 137: Sorin Group Pipeline Products by Clinical Trials 206
Table 138: Sorin Group Pipeline Products by News Summary 206
Table 139: Philips Medical Systems Pipeline Products by Equipment Type 211
Table 140: Philips Medical Systems Pipeline Products by Development Stage 211
Table 141: Philips Medical Systems Pipeline Products by Therapy Area 212
Table 142: Philips Medical Systems Pipeline Products by Clinical Trials 212
Table 143: Philips Medical Systems Pipeline Products by News Summary 212
Table 144: Edwards Lifesciences Corporation Pipeline Products by Equipment Type 225
Table 145: Edwards Lifesciences Corporation Pipeline Products by Development Stage 226
Table 146: Edwards Lifesciences Corporation Pipeline Products by Therapy Area 226
Table 147: Edwards Lifesciences Corporation Pipeline Products by Clinical Trials 227
Table 148: Edwards Lifesciences Corporation Pipeline Products by News Summary 227
Table 149: Thoratec Corporation Pipeline Products by Equipment Type 231
Table 150: Thoratec Corporation Pipeline Products by Development Stage 231
Table 151: Thoratec Corporation Pipeline Products by Therapy Area 231
Table 152: Thoratec Corporation Pipeline Products by Clinical Trials 232
Table 153: Thoratec Corporation Pipeline Products by News Summary 232
Table 154: Arrow International, Inc. Pipeline Products by Equipment Type 239
Table 155: Arrow International, Inc. Pipeline Products by Development Stage 239
Table 156: Arrow International, Inc. Pipeline Products by Therapy Area 239
Table 157: Arrow International, Inc. Pipeline Products by Clinical Trials 239
Table 158: ABIOMED, Inc. Pipeline Products by Equipment Type 243
Table 159: ABIOMED, Inc. Pipeline Products by Development Stage 243
Table 160: ABIOMED, Inc. Pipeline Products by Therapy Area 243
Table 161: ABIOMED, Inc. Pipeline Products by Clinical Trials 244
Table 162: ABIOMED, Inc. Pipeline Products by News Summary 244
Table 163: AtriCure, Inc. Pipeline Products by Equipment Type 246
Table 164: AtriCure, Inc. Pipeline Products by Development Stage 246
Table 165: AtriCure, Inc. Pipeline Products by Therapy Area 247
Table 166: AtriCure, Inc. Pipeline Products by Clinical Trials 247
Table 167: AtriCure, Inc. Pipeline Products by News Summary 247
Table 168: Terumo Corporation Pipeline Products by Equipment Type 250
Table 169: Terumo Corporation Pipeline Products by Development Stage 250
Table 170: Terumo Corporation Pipeline Products by Therapy Area 250
Table 171: Terumo Corporation Pipeline Products by Clinical Trials 251
Table 172: Terumo Corporation Pipeline Products by News Summaries 251
Table 173: CryoCath Technologies Inc. Pipeline Products by Equipment Type 253
Table 174: CryoCath Technologies Inc. Pipeline Products by Development Stage 253
Table 175: CryoCath Technologies Inc. Pipeline Products by Therapy Area 253
Table 176: CryoCath Technologies Inc. Pipeline Products by Clinical Trials 254
Table 177: CryoCath Technologies Inc. Pipeline Products by News Summary 254
Table 178: C.R. Bard, Inc. Pipeline Products by Equipment Type 260
Table 179: C.R. Bard, Inc. Pipeline Products by Development Stage 261
Table 180: C.R. Bard, Inc. Pipeline Products by Therapy Area 261
Table 181: C.R. Bard, Inc. Pipeline Products by Clinical Trials 262
Table 182: Invatec S.r.l. Pipeline Products by Equipment Type 263
Table 183: Invatec S.r.l. Pipeline Products by Development Stage 264
Table 184: Invatec S.r.l. Pipeline Products by Therapy Area 265
Table 185: Invatec S.r.l. Pipeline Products by Clinical Trials 266
Table 186: Invatec S.r.l. Pipeline Products by News Summary 266
Table 187: ev3 Inc. Pipeline Products by Equipment Type 270
Table 188: ev3 Inc. Pipeline Products by Development Stage 270
Table 189: ev3 Inc. Pipeline Products by Therapy Area 271
Table 190: ev3 Inc. Pipeline Products by Clinical Trials 271
Table 191: ev3 Inc. Pipeline Products by News Summary 271
Table 192: Berlin Heart GmbH Pipeline Products by Equipment Type 276
Table 193: Berlin Heart GmbH Pipeline Products by Development Stage 276
Table 194: Berlin Heart GmbH Pipeline Products by Therapy Area 277
Table 195: Berlin Heart GmbH Pipeline Products by Clinical Trials 277
Table 196: Berlin Heart GmbH Pipeline Products by News Summary 277
Table 197: CardioBridge GmbH Pipeline Products by Equipment Type 279
Table 198: CardioBridge GmbH Pipeline Products by Development Stage 279
Table 199: CardioBridge GmbH Pipeline Products by Therapy Area 279
Table 200: CardioBridge GmbH Pipeline Products by Clinical Trials 280
Table 201: CardioBridge GmbH Pipeline Products by News Summary 280
Table 202: Eurocor GmbH Pipeline Products by Equipment Type 281
Table 203: Eurocor GmbH Pipeline Products by Development Stage 282
Table 204: Eurocor GmbH Pipeline Products by Therapy Area 282
Table 205: Eurocor GmbH Pipeline Products by Clinical Trials 283
Table 206: Eurocor GmbH Pipeline Products by News Summary 283
Table 207: JenaValve Technology GmbH Pipeline Products by Equipment Type 284
Table 208: JenaValve Technology GmbH Pipeline Products by Development Stage 284
Table 209: JenaValve Technology GmbH Pipeline Products by Therapy Area 284
Table 210: Translumina GmbH Pipeline Products by Equipment Type 285
Table 211: Translumina GmbH Pipeline Products by Development Stage 285
Table 212: Translumina GmbH Pipeline Products by Therapy Area 286
Table 213: Translumina GmbH Pipeline Products by Clinical Trials 286
Table 214: USD to Local Currency, Average Exchange Rate 2008 294
1.2 List of Figures
Figure 1: Healthcare Structure in Germany, 2000 - 2006 34
Figure 2: Healthcare Expenditure Sources in Germany, 2003 35
Figure 3: Healthcare Financing Framework in Germany 36
Figure 4: Flowchart for Classification of Non-invasive Devices in Germany, 2007 46
Figure 5: Flowchart for Classification of Invasive Devices in Germany, 2007 47
Figure 6: Flowchart for Classification of Invasive Devices in Germany, 2007 48
Figure 7: Classification of Invasive Devices in Germany, 2007 49
Figure 8: Classification of Invasive Devices in Germany, 2007 50
Figure 9: Flowchart for Classification of Active Devices in Germany, 2007 51
Figure 10: Flowchart for Classification of Active Devices in Germany, 2007 52
Figure 11: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Germany, 2007 53
Figure 12: Conformity Assessment of Class-I Medical Devices in Germany, 2007 54
Figure 13: Conformity Assessment of Class-IIa Medical Devices in Germany, 2007 55
Figure 14: Conformity Assessment of Class-IIb Medical Devices in Germany, 2007 56
Figure 15: Conformity Assessment of Class-III Medical Devices in Germany, 2007 57
Figure 16: Cardiovascular Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015 61
Figure 17: Cardiovascular Devices, Germany, Overall Revenue ($ mn), 2000-2015 62
Figure 18: Cardiovascular Devices, Germany, Cross-Category Analysis, 2000-2015 63
Figure 19: Cardiovascular Devices, Germany, Overall Revenue ($ mn), Historic, 2000-2008 64
Figure 20: Cardiovascular Devices, Germany, Overall Revenue ($ mn), Forecast, 2008-2015 66
Figure 21: Cardiovascular Devices, Germany, Category Volume (Units), Historic, 2000-2008 69
Figure 22: Cardiovascular Devices, Germany, Category Volume (Units), Forecast, 2008-2015 71
Figure 23: Cardiovascular Devices, Germany, Company Share (%), 2008 73
Figure 24: Cardiac Rhythm Management, Germany, Revenue ($ mn) by Segment, Historic, 2000-2008 74
Figure 25: Cardiac Rhythm Management, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015 75
Figure 26: Cardiac Resynchronisation Therapy, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 76
Figure 27: Cardiac Resynchronisation Therapy, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 77
Figure 28: Implantable Cardioverter Defibrillator, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 78
Figure 29: Implantable Cardioverter Defibrillator, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 79
Figure 30: Pacemaker, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 80
Figure 31: Pacemaker, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 81
Figure 32: Cardiac Rhythm Management, Germany, Volume (Units) by Segment, Historic, 2000-2008 82
Figure 33: Cardiac Rhythm Management, Germany, Volume (Units) by Segment, Forecast, 2008-2015 83
Figure 34: Cardiac Resynchronisation Therapy, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008 84
Figure 35: Cardiac Resynchronisation Therapy, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015 85
Figure 36: Implantable Cardioverter Defibrillator, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008 86
Figure 37: Implantable Cardioverter Defibrillator, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015 87
Figure 38: Pacemaker, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008 88
Figure 39: Pacemaker, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015 89
Figure 40: Cardiac Rhythm Management, Germany, Company Share (%), 2008 92
Figure 41: Cardiovascular Monitoring and Diagnostic Devices, Germany, Revenue ($ mn) by Segment, Historic, 2000-2008 93
Figure 42: Cardiovascular Monitoring and Diagnostic Devices, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015 95
Figure 43: Cardiovascular Monitoring and Diagnostic Devices, Germany, Volume (Units) by Segment, Historic, 2000-2008 96
Figure 44: Cardiovascular Monitoring and Diagnostic Devices, Germany, Volume (Units) by Segment, Forecast, 2008-2015 97
Figure 45: Cardiovascular Monitoring and Diagnostic Devices, Germany, Company Share (%), 2008 100
Figure 46: Cardiovascular Prosthetic Devices, Germany, Revenue ($ mn) by Segment, Historic, 2000-2008 102
Figure 47: Cardiovascular Prosthetic Devices, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015 103
Figure 48: Cardiac Assist Devices, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 104
Figure 49: Cardiac Assist Devices, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 105
Figure 50: Prosthetic Heart Valve, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 106
Figure 51: Prosthetic Heart Valve, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 107
Figure 52: Cardiovascular Prosthetic Devices, Germany, Volume (Units) by Segment, Historic, 2000-2008 108
Figure 53: Cardiovascular Prosthetic Devices, Germany, Volume (Units) by Segment, Forecast, 2008-2015 109
Figure 54: Cardiac Assist Devices, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008 110
Figure 55: Cardiac Assist Devices, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015 111
Figure 56: Prosthetic Heart Valve, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008 112
Figure 57: Prosthetic Heart Valve, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015 113
Figure 58: Cardiovascular Prosthetic Devices, Germany, Company Share (%), 2008 116
Figure 59: Cardiovascular Surgery, Germany, Revenue ($ mn) by Segment, Historic, 2000-2008 117
Figure 60: Cardiovascular Surgery, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015 118
Figure 61: Perfusion Disposables, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 119
Figure 62: Perfusion Disposables, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 120
Figure 63: Perfusion Disposables, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008 122
Figure 64: Perfusion Disposables, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015 123
Figure 65: Cardiovascular Surgery, Germany, Company Share (%), 2008 126
Figure 66: Electrophysiology, Germany, Revenue ($ mn) by Segment, Historic, 2000-2008 127
Figure 67: Electrophysiology, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015 128
Figure 68: Electrophysiology, Germany, Company Share (%), 2008 132
Figure 69: Interventional Cardiology, Germany, Revenue ($ mn) by Segment, Historic, 2000-2008 134
Figure 70: Interventional Cardiology, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015 136
Figure 71: Cardiac Catheter, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 138
Figure 72: Cardiac Catheter, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 139
Figure 73: Coronary Stent, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 140
Figure 74: Coronary Stent, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 141
Figure 75: PTCA Balloon, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 142
Figure 76: PTCA Balloon, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 143
Figure 77: Interventional Cardiology, Germany, Volume (Units) by Segment, Historic, 2000-2008 144
Figure 78: Interventional Cardiology, Germany, Volume (Units) by Segment, Forecast, 2008-2015 145
Figure 79: Cardiac Catheter, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008 146
Figure 80: Cardiac Catheter, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015 147
Figure 81: Coronary Stent, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008 148
Figure 82: Coronary Stent, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015 149
Figure 83: PTCA Balloon, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008 150
Figure 84: PTCA Balloon, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015 151
Figure 85: Interventional Cardiology, Germany, Company Share (%), 2008 155
Figure 86: Peripheral Vascular Devices, Germany, Revenue ($ mn) by Segment, Historic, 2000-2008 156
Figure 87: Peripheral Vascular Devices, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015 158
Figure 88: Peripheral Vascular Devices, Germany, Company Share (%), 2008 164
Figure 89: Boston Scientific Corporation Value Chain Analysis 166
Figure 90: Medtronic, Inc. Value Chain Analysis 175
Figure 91: Abbott Laboratories Value Chain Analysis 189
Figure 92: St. Jude Medical Inc. Value Chain Analysis 192
Figure 93: Sorin Group Value Chain Analysis 201
Figure 94: Philips Medical Systems Value Chain Analysis 208
Figure 95: OSI Systems, Inc. Value Chain Analysis 214
Figure 96: Cardiac Science Corporation Value Chain Analysis 217
Figure 97: Nihon Kohden Corporation Value Chain Analysis 220
Figure 98: Edwards Lifesciences Corporation Value Chain Analysis 223
Figure 99: Thoratec Corporation Value Chain Analysis 229
Figure 100: Datascope Corp. Value Chain Analysis 233
Figure 101: Arrow International, Inc. Value Chain Analysis 237
Figure 102: ABIOMED, Inc. Value Chain Analysis 241
Figure 103: Terumo Corporation Value Chain Analysis 248
Figure 104: Siemens Medical Solutions Value Chain Analysis 256
Figure 105: C.R. Bard, Inc. Value Chain Analysis 258
Figure 106: ev3 Inc. Value Chain Analysis 268
Figure 107: Global Markets Direct Methodology 290
|
